Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).
Amgen
Amgen
Eli Lilly and Company
Rondo Therapeutics
Dragonfly Therapeutics
Merck Sharp & Dohme LLC
NeoImmuneTech
Revolution Medicines, Inc.
Hoffmann-La Roche
Amgen
Ankara Etlik City Hospital
Tizona Therapeutics, Inc
Essen Biotech
Werewolf Therapeutics, Inc.
Novartis
Inhibrx Biosciences, Inc
Sairopa B.V.
Amgen
Coherus Oncology, Inc.
University of Kentucky
Krystal Biotech, Inc.
Hummingbird Bioscience
Daiichi Sankyo
Qilu Pharmaceutical Co., Ltd.
Trishula Therapeutics, Inc.
NuCana plc
Medicenna Therapeutics, Inc.
Trishula Therapeutics, Inc.
DEKA Biosciences
Inspirna, Inc.
GlaxoSmithKline
Intensity Therapeutics, Inc.
GV20 Therapeutics
Merck Sharp & Dohme LLC
Carisma Therapeutics Inc
Eli Lilly and Company
Vincerx Pharma, Inc.
Simcha IL-18, Inc.
Salubris Biotherapeutics Inc
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Aetion, Inc.
Aetion, Inc.
National Cancer Institute (NCI)
Coherus Oncology, Inc.
R-Pharm
Mural Oncology, Inc
GlaxoSmithKline
Heat Biologics
Aetion, Inc.
Lithuanian University of Health Sciences
Kineta Inc.